Fusionsprotein

European patent · EP0293249 · Deleted

Register entry

Publication number
EP0293249
Application number
EP88304868
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
May 27, 1988
Published
Nov 30, 1988
Granted
Aug 26, 1992
Deleted
May 26, 2008
Reason
Maximum term reached
IPC classes
C12N 15/62 (2006.01)
C07H 21/04 (2006.01)
C12N 5/00 (2006.01)
C12P 21/00 (2006.01)
Priority
AU A 2195/87 28.05.1987
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jun 30, 2008

    Maximum term reached

    Published in +pat+ No 12 in 2008

  2. Sep 28, 2007

    Agent entered

    Representative
    Bugnion S.A., Case postale 375, 1211 Genève 12 - Champel

    Published in +pat+ No 18 in 2007

  3. Sep 28, 2007

    Transferred

    Owner
    Chemicon International Inc., 28820 Single Oak Drive, Temecula, California, USA → SEROLOGICALS CORPORATION, 5655 Spalding Drive, Norcross, GA 30092, USA

    Published in +pat+ No 18 in 2007

  4. Sep 28, 2007

    Transferred

    Owner
    SEROLOGICALS CORPORATION, 5655 Spalding Drive, Norcross, GA 30092, USA → MILLIPORE CORPORATION, 290 Concord Road, Billerica, MA 01821, USA

    Published in +pat+ No 18 in 2007

  5. Feb 28, 2003

    Transferred

    Owner
    Amrad Corporation Limited, 17-27 Cotham Road, Kew/VIC, Australia → Chemicon International Inc., 28820 Single Oak Drive, Temecula, California, USA

    Published in +pat+ No 4 in 2003

  6. Oct 15, 1992

    Granted

    Published in PIDTJ No 19 in 1992

Parties

Inventor

Smith, Donald Bruce

Berwickshire TD13 5XE Scotland, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.